公开(公告)号：US20240299346A1

公开(公告)日：2024-09-12

申请号：US18596418

申请日：2024-03-05

申请人： Phi Health Sciences, Inc.

发明人： John-Paul Rowland ANDERSEN ,  Kirk Roy OUIMET

IPC分类号： A61K31/375 ,  A61K9/50 ,  A61K31/07 ,  A61K31/593 ,  A61K31/714 ,  A61K33/06 ,  A61K33/26 ,  A61K33/30 ,  A61K33/34

CPC分类号： A61K31/375 ,  A61K9/5084 ,  A61K31/07 ,  A61K31/593 ,  A61K31/714 ,  A61K33/06 ,  A61K33/26 ,  A61K33/30 ,  A61K33/34

摘要： A dietary supplement bead may include a body comprising iron and vitamin C. A dietary supplement bead may include a microencapsulating material in the body, the microencapsulating material facilitating a sustained release of the iron and the vitamin C simultaneously within a small intestine of a user.

公开(公告)号：US12083130B2

公开(公告)日：2024-09-10

申请号：US17255927

申请日：2020-10-01

申请人： Caren Pharmaceuticals, Inc.

发明人： Arnold Edward Friedman ,  Rebecca L. Glaser

IPC分类号： A61K31/57 ,  A61K31/4196 ,  A61K31/473 ,  A61K31/568 ,  A61K31/573 ,  A61K31/593 ,  A61P25/28

CPC分类号： A61K31/57 ,  A61K31/4196 ,  A61K31/473 ,  A61K31/568 ,  A61K31/573 ,  A61K31/593 ,  A61P25/28

摘要： Disclosed herein are compositions and methods useful for the treatment or amelioration of various diseases, disorders, or conditions. Some aspects pertain to a composition comprising a testosterone source, an aromatase inhibitor, and an estriol source. Also presented herein is the surprising discovery that exposing a subject to the compositions disclosed herein can increase a subject's longevity, survival time, life span, and health span, as well as treat Alzheimer's disease.

公开(公告)号：US20240277628A1

公开(公告)日：2024-08-22

申请号：US18650432

申请日：2024-04-30

申请人： ELEMENTIS SPECIALTIES, INC.

发明人： Joseph Anthony LUPIA ,  Kimberly BURCH ,  Wouter IJDO

IPC分类号： A61K31/05 ,  A61K9/06 ,  A61K9/107 ,  A61K31/07 ,  A61K31/355 ,  A61K31/375 ,  A61K31/593 ,  A61K36/16 ,  A61K36/185 ,  A61K36/258 ,  A61K36/28 ,  A61K36/42 ,  A61K36/53 ,  A61K36/82 ,  A61K36/886 ,  A61K45/06 ,  A61K47/02 ,  A61K47/10 ,  A61K47/18 ,  A61K47/22 ,  A61K47/44

CPC分类号： A61K31/05 ,  A61K9/06 ,  A61K9/107 ,  A61K31/07 ,  A61K31/355 ,  A61K31/375 ,  A61K31/593 ,  A61K36/16 ,  A61K36/185 ,  A61K36/258 ,  A61K36/28 ,  A61K36/42 ,  A61K36/53 ,  A61K36/82 ,  A61K36/886 ,  A61K45/06 ,  A61K47/02 ,  A61K47/10 ,  A61K47/186 ,  A61K47/22 ,  A61K47/44

摘要： A cannabidiol (CBD) gelled delivery system comprising: a rheology modifier; an emollient; and one or more cannabidiols selected from the group consisting of a cannabidiol broad spectrum oil, a cannabidiol full spectrum oil, or a cannabidiol isolate. A CBD emulsified delivery system comprising: a rheology modifier; an emollient; a polyglyceryl ester surfactant; and one or more cannabidiols selected from the group consisting of a cannabidiol broad spectrum oil, a cannabidiol full spectrum oil, or a cannabidiol isolate. For such delivery systems, the cannabidiols contain less than 0.3 wt. % of tetrahydrocannabinol (THC) or the cannabidiols are substantially free of THC. An active gelled delivery system a rheology modifier; an emollient; and one or more actives. An active emulsified delivery system comprising: a rheology modifier; an emollient; a polyglyceryl ester surfactant; and one or more actives.

公开(公告)号：US20240252647A1

公开(公告)日：2024-08-01

申请号：US18456612

申请日：2023-08-28

申请人： Journey Medical Corporation

发明人： Dov Tamarkin ,  Elana Gazal ,  Yohan Hazot ,  David Schuz ,  Irakliy Papiashvili

IPC分类号： A61K47/44 ,  A61K8/31 ,  A61K8/34 ,  A61K8/36 ,  A61K9/00 ,  A61K9/12 ,  A61K31/137 ,  A61K31/192 ,  A61K31/4164 ,  A61K31/57 ,  A61K31/573 ,  A61K31/593 ,  A61K31/65 ,  A61K45/06 ,  A61K47/02 ,  A61K47/06 ,  A61K47/10 ,  A61K47/12 ,  A61K47/24 ,  A61Q17/04 ,  A61Q19/00 ,  A61Q19/10

CPC分类号： A61K47/44 ,  A61K8/31 ,  A61K8/342 ,  A61K8/361 ,  A61K9/0014 ,  A61K9/0048 ,  A61K9/12 ,  A61K9/122 ,  A61K9/124 ,  A61K31/137 ,  A61K31/192 ,  A61K31/4164 ,  A61K31/57 ,  A61K31/573 ,  A61K31/593 ,  A61K31/65 ,  A61K45/06 ,  A61K47/02 ,  A61K47/06 ,  A61K47/10 ,  A61K47/12 ,  A61K47/24 ,  A61Q17/04 ,  A61Q19/00 ,  A61Q19/10 ,  A61K2800/31 ,  A61K2800/33

摘要： The present disclosure relates generally to compositions for cosmetic or pharmaceutical application. The compositions include a carrier and rheology modulators.APP

公开(公告)号：US20240156720A1

公开(公告)日：2024-05-16

申请号：US18419852

申请日：2024-01-23

申请人： Albert Einstein College of Medicine

发明人： Joel M. Friedman

IPC分类号： A61K9/00 ,  A61K9/06 ,  A61K31/05 ,  A61K31/12 ,  A61K31/121 ,  A61K31/352 ,  A61K31/366 ,  A61K31/4375 ,  A61K31/593 ,  A61K47/10 ,  A61K47/12 ,  A61P7/00 ,  A61P37/06

CPC分类号： A61K9/0014 ,  A61K9/06 ,  A61K31/05 ,  A61K31/12 ,  A61K31/121 ,  A61K31/352 ,  A61K31/366 ,  A61K31/4375 ,  A61K31/593 ,  A61K47/10 ,  A61K47/12 ,  A61P7/00 ,  A61P37/06

摘要： Formulations comprising one or more active agents for blood storage and transfusions are provided. Also provided methods for prolonging viability of blood and enhancing efficacy of blood transfusion.

公开(公告)号：US11975052B2

公开(公告)日：2024-05-07

申请号：US17156534

申请日：2021-01-23

申请人： Chenland Nutritionals Inc. ,  Qingdao Chenland Pharmaceutical Technology Development Co., Ltd.

发明人： Shengcan Zou ,  Zengliang Zhang ,  Jiancheng Zong ,  Wenyu Li ,  Xin Li ,  Li Li ,  Shanglong Wang ,  Lei Zong

IPC分类号： A61K38/39 ,  A23J3/34 ,  A23L29/281 ,  A23L33/00 ,  A23L33/105 ,  A23L33/155 ,  A23L33/16 ,  A23L33/17 ,  A61K31/122 ,  A61K31/593 ,  A61K33/06 ,  A61K36/126 ,  A61K36/39 ,  A61K36/46 ,  A61P19/00

CPC分类号： A61K38/39 ,  A23L29/284 ,  A23L33/105 ,  A23L33/155 ,  A23L33/16 ,  A23L33/17 ,  A23L33/40 ,  A61K31/122 ,  A61K31/593 ,  A61K33/06 ,  A61K36/126 ,  A61K36/39 ,  A61K36/46 ,  A61P19/00 ,  A23J3/342 ,  A23V2002/00 ,  A23V2250/5422 ,  A61K2236/31 ,  A61K2236/333 ,  A61K2236/37 ,  A61K2236/51 ,  A61K2236/53

摘要： A compound composition for improving bone health and preparation and application thereof are provided. The compound composition is prepared by combining a traditional Chinese medicine extract with chicken cartilage collagen, magnesium, vitamin K2 and vitamin D3. The compound composition overcomes the food safety risk of the existing osteoporosis preventive drugs by adding the traditional Chinese medicine extract for improving osteoporosis and promoting bone health. And the compound composition disclosed can be used as a dietary supplement or health food raw material for preventing or treating osteoporosis. Therefore, the compound composition disclosed is suitable for promotion and application.

公开(公告)号：US20240123013A1

公开(公告)日：2024-04-18

申请号：US18275597

申请日：2022-02-07

申请人： CS Medica A/S

发明人： Lone Henriksen ,  Rosemarie Dauer ,  Maria Agustina Duguine

IPC分类号： A61K36/324 ,  A61K9/00 ,  A61K9/06 ,  A61K9/48 ,  A61K31/00 ,  A61K31/375 ,  A61K31/445 ,  A61K31/593 ,  A61K36/9066 ,  A61P17/06 ,  A61P19/02

CPC分类号： A61K36/324 ,  A61K9/0014 ,  A61K9/0056 ,  A61K9/06 ,  A61K9/4866 ,  A61K31/375 ,  A61K31/445 ,  A61K31/593 ,  A61K31/658 ,  A61K36/9066 ,  A61P17/06 ,  A61P19/02

摘要： The present invention relates to an oral composition for use in the treatment and/or alleviation of symptoms such as pain and/or discomfort in a subject, such as pain or discomfort related to arthritis, or psoriasis. Such a treatment may further comprise application of a cannabinoid-comprising topical composition, such a CBD-comprising composition, such as a CBD-comprising hydroalcoholic gels. Different compositions comprising 3-O-Acetyl-11-Keto Beta Boswellic Acid, Curcuminoid, Vitamin C, and Vitamin D are disclosed.

公开(公告)号：US11951144B2

公开(公告)日：2024-04-09

申请号：US17268316

申请日：2018-09-12

申请人： PM-INTERNATIONAL AG

发明人： Rolf Sorg ,  Tobias Kühne ,  Christian Lauinger ,  Wilhelm Messer

IPC分类号： A61K36/00 ,  A23L33/105 ,  A23L33/125 ,  A23L33/135 ,  A23L33/14 ,  A23L33/15 ,  A23L33/16 ,  A23L33/22 ,  A61K31/12 ,  A61K31/197 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/519 ,  A61K31/522 ,  A61K31/525 ,  A61K31/593 ,  A61K31/714 ,  A61K33/06 ,  A61K33/30 ,  A61K33/34 ,  A61K35/20 ,  A61K36/064 ,  A61K36/67 ,  A61K36/9068 ,  A61K47/12 ,  A61K47/26 ,  A61K47/36 ,  A61K47/46 ,  A61K47/69

CPC分类号： A61K36/67 ,  A23L33/105 ,  A23L33/125 ,  A23L33/135 ,  A23L33/14 ,  A23L33/15 ,  A23L33/16 ,  A23L33/22 ,  A61K31/12 ,  A61K31/197 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/519 ,  A61K31/522 ,  A61K31/525 ,  A61K31/593 ,  A61K31/714 ,  A61K33/06 ,  A61K33/30 ,  A61K33/34 ,  A61K35/20 ,  A61K36/064 ,  A61K36/9068 ,  A61K47/12 ,  A61K47/26 ,  A61K47/36 ,  A61K47/46 ,  A61K47/6951 ,  A23V2002/00 ,  A23V2400/113 ,  A23V2400/173

摘要： A composition, containing



a pepper component,
a curcumin-cyclodextrin mixture and
a mixture of fruits, vegetables and spices.

公开(公告)号：US11938100B2

公开(公告)日：2024-03-26

申请号：US17385611

申请日：2021-07-26

申请人： Kedar Prasad

发明人： Kedar Prasad

IPC分类号： A61K31/07 ,  A23L33/105 ,  A23L33/155 ,  A23L33/16 ,  A61K31/015 ,  A61K31/05 ,  A61K31/12 ,  A61K31/122 ,  A61K31/197 ,  A61K31/198 ,  A61K31/352 ,  A61K31/355 ,  A61K31/375 ,  A61K31/385 ,  A61K31/4188 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/519 ,  A61K31/525 ,  A61K31/593 ,  A61K31/714 ,  A61K33/04 ,  A61K33/06 ,  A61K33/24 ,  A61K33/30

CPC分类号： A61K31/07 ,  A23L33/105 ,  A23L33/155 ,  A23L33/16 ,  A61K31/015 ,  A61K31/05 ,  A61K31/12 ,  A61K31/122 ,  A61K31/197 ,  A61K31/198 ,  A61K31/352 ,  A61K31/355 ,  A61K31/375 ,  A61K31/385 ,  A61K31/4188 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/519 ,  A61K31/525 ,  A61K31/593 ,  A61K31/714 ,  A61K33/04 ,  A61K33/06 ,  A61K33/24 ,  A61K33/30 ,  A23V2002/00

摘要： A formulation comprising at least on vitamin, at least one antioxidant, at least one mineral, at least one plant based nutrient and sodium.

公开(公告)号：US11903952B2

公开(公告)日：2024-02-20

申请号：US17303330

申请日：2021-05-26

申请人： NORTHWESTERN UNIVERSITY ,  Case Western Reserve University ,  The Regents of the University of Colorado

发明人： Kurt Q. Lu ,  Livia A. Veress ,  Kevin D. Cooper ,  Amisha Wallia

IPC分类号： A61K31/593 ,  A61K45/06 ,  A61P31/14 ,  A61P11/00 ,  A61K31/585

CPC分类号： A61K31/593 ,  A61K31/585 ,  A61K45/06 ,  A61P11/00 ,  A61P31/14

摘要： Disclosed herein are methods and compositions useful in reducing inflammation, reducing inflammatory exudates, enhancing epithelial tissue generation or regeneration, and/or reducing mean pulmonary artery pressure in the lungs of a subject in need thereof. In particular, the compositions comprise vitamin D, an analog, or metabolite thereof, and the methods include administering the composition to a subject in need thereof. In some embodiments, the subject is suffering from an infection, such as a viral infection, which affects the lungs. In some embodiments, the viral infection comprises SARS-CoV-2.